Source: San Diego Union-Tribune
“U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting ‘the health interests of Americans,’ under a new initiative announced Tuesday. Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA’s long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months. … For the new program, the FDA will issue a limited number of ‘national priority vouchers’ to companies ‘aligned with U.S. national priorities,’ the agency said in a statement.” [editor’s note: In English, “make bigger campaign contributions, face less red tape” – TLK] (06/17/25)
https://www.sandiegouniontribune.com/2025/06/17/fda-faster-drug-reviews/